Why Exact Sciences Shares Rallied 16.7% in October
After reporting third-quarter financial results that were better than expected, Exact Sciences (NASDAQ: EXAS) shares gained 16.7% in October, according to S&P Global Market Intelligence.
Exact Sciences' quarterly results show that more doctors and patients are choosing its Cologuard test for colon cancer screening.
Source: Fool.com